Rocket Pharma (DE:9IP1)
NASDAQ:9IP1
Earnings Data
Report Date
Aug 10, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.89Last Year’s EPS
-0.53Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
DE:9IP1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:9IP1 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | €3.09 | €2.92 | -5.50% |
Feb 26, 2026 | €3.46 | €3.73 | +7.80% |
Nov 06, 2025 | €2.68 | €2.69 | +0.41% |
Aug 07, 2025 | €2.39 | €2.43 | +1.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Rocket Pharma (DE:9IP1) report earnings?
Rocket Pharma (DE:9IP1) is schdueled to report earning on Aug 10, 2026, Before Open (Confirmed).
What is Rocket Pharma (DE:9IP1) earnings time?
Rocket Pharma (DE:9IP1) earnings time is at Aug 10, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Rocket Pharma stock?
The P/E ratio of Rocket Pharmaceuticals is N/A.
What is DE:9IP1 EPS forecast?
DE:9IP1 EPS forecast for the fiscal quarter 2026 (Q2) is 0.89.